Scholars Central

Conference abstractPublished 16 Aug 2023

Tackling triple negative breast cancer through nanotechnological interventions: Promise and pitfalls

Authors: Partha Roy

GITAM School of Pharmacy, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Global socioeconomic revolution with overlying stress motivators remains as the main stimulus behind rising cancer cases across global frontiers. Among diverse cancer variants, female breast cancer has emerged as the most detected type although it is predominantly gender selective. This stands out as the prominent cause of the rapid spread of the disease. Triple Negative Breast Cancer (TNBC) is an extremely intrusive variant of BC and is visible in approximately 20% of all BC cases. Moreover, the disease offers poor prognosis with increased risk of relapse after conventional chemotherapy. TNBC also leads to metastasis of the lung, liver and brain and presents the highest death rate among all other breast cancer types. Spotlight on the etiology of TNBC related mortality confirms tumour migration and ancillary tumour growth in migrated sites as the pivotal causes. Adding to the complexity, strategies for TNBC management often involves non-targeted chemotherapeutic schedules leading to undesired fatalities, as the disease lacks suitable targets like Estrogen Receptor, Progesterone Receptor and HER-2 Receptor. Contemporary treatment strategy for TNBC involves a blend of chemotherapy, surgery and radiation depending on the patient condition. Designing formulation stratagems for site-directed nanotherapeutics can provide a suitable solution to the complex clinical condition. However, biocompatibility and absence of residual toxicity remains a major challenge in the clinical translation of these technology-guided newer therapeutic arsenals.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Breast Cancer: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBreast Cancer: Current Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Partha Roy”